Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
allogeneic blood cells (1 trial)
autologous blood (1 trial)
dapagliflozin (farxiga) (1 trial)
gliclazide (1 trial)
insulin human (humulin) (1 trial)
liraglutide (victoza) (1 trial)
metformin (glucophage) (1 trial)
pioglitazone (actos) (1 trial)
sitagliptin (januvia) (1 trial)
Hematologic Diseases (Phase 3)
Trials (3 total)
Trial APIs (9 total)